<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE html><html xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <meta http-equiv="Content-Type" content="text/html;charset=UTF-8" />
    <title>Drug-Receptor interaction</title>
  </head>
  <body>
    <h1>                                                         Drug-Receptor
      Interaction</h1>
    <h2 style="width: 906px;">Key points</h2>
    <p style="width: 987px;"> The main concept of Pharmacodynamics is the
      binding of one protein (P) and its ligand (L)  to form the complex
      (PL)--&gt;the interaction is reversible and non covalent and is
      represented as a chemical equilibrium (image) <img alt="" src="data:image/png;base64,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"
        style="width: 174px; margin-left: 478px;" /></p>
    <p style="width: 987px;">-The <em>protein</em> is the Drug target: enzymes,
      metabolites, protein, receptors, ion channel, transporters,DNA..the <em>ligand</em>
      is the Drug.</p>
    <p style="width: 987px;">-The drug interaction happens in a water
      environment, when the interaction takes place the water molecules have to
      be removed <img alt="" src="data:image/png;base64,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" /></p>
    <p style="width: 987px;">based on the thermodynamic equation.<br />
    </p>
    <p style="width: 1285px;">-Interactions between the protein and the ligand
      are non-covalent --&gt; semplifications are required to study the <u>intermolecular
        interactions</u> --&gt; <em>classical mechanics </em>where forces of
      the interaction between two atoms are related to potential where the
      potential equation, described by the ionic interaction, is inversely
      proportional to the distance.</p>
    <p style="width: 1285px;">-<em>Hydrophobic effect</em>: considering two
      polar substances in the unaggregated state, water molecules are highly
      ordered and the entropy (ΔS) is lower energetically unfavourable. When the
      hydrophobic aggregation takes place the water population appears less
      ordered: there is an higher entropy and it results energetically more
      favourable. According to the thermodynamic equation an increase of entropy
      induce a negative free Energy (ΔG).<br />
    </p>
    <p style="width: 987px;">-All the non covalent bonds are weak
      interactions---&gt; <em>cooperative effect</em> all together create a
      strong bonding (but reversible)<br />
    </p>
    <p style="width: 1291px;">ionic bond (the strongest non-covalent bond)&gt;
      ione-dipole&gt; dipole-dipole--&gt; they occurs because there is a charge
      difference between the two atoms involved in a bond <br />
    </p>
    <p style="width: 1291px;">-Conformational effects: small molecules rarely
      bind to proteins outside of their preferred minimum energy conformations,</p>
    <h2 style="width: 987px;">Summary of the article</h2>
    <p>-DHPs are used to inhibit VGCC, whose disfunctions are involved in
      various pathological conditions (cardiovascular disorder to psychiatric
      and neurological syndrome). DHPs exhibit chirality-specific antagonistic
      or agonistic effects. this article provides a more comprehensive
      understanding of the MOA of DHP drugs<br />
    </p>
    <p>-rCa1.1 as a prototype for cryo-EM analysis of VGIC members purified in
      detergent micelles, but it's unclear if this altered local structure of
      dynamics channel--&gt;It was demonstrated that structures of Ca1.1 in
      lipid nanodiscs are nearly identical to those in glyco-diosgenin micelles
      (RMSD of 0.55A), the coordination of backbones of all resolved DHP
      antagonist is conserved regardless the surrounding environment.<br />
    </p>
    <p>-Secondly researchers want to study if the agonist SBK at lower
      concentration may lock the channel in an activated state, but all
      structures with the addition of enantiomers exhibit similar inactivated
      conformations(apply SBK at different doses and in different environment)
      suggesting that S- , when acting as an agonist, is insufficient to lock
      the activated state of the channel for a prolonged duration.  <br />
    </p>
    <p>-Furthermore it is studied how the bigger groups of some DHP drugs, such
      as levamlopidine are coordinated by DHPR.The bulky substituent of
      amlodipine is the <em>ethanol group</em> (+charged, change
      pharmacokinetics properties), points to the central cavity of the PD (pore
      domain), except for this, the other interactions are H bonds. Direct
      participation of a phospholipid in the coordination of amlodipine
      (interact with ethanolamine) is intriguing , but unclear (the resolution
      is insufficient). the amlodipine-bound structure reveals the molecular
      basis for the high efficacy of the drug.<br />
    </p>
    <p><br />
    </p>
    <p style="width: 987px;"><br />
    </p>
    <p style="width: 987px;"></p>
    <p style="width: 987px;"><br />
    </p>
  </body>
</html>
